Armata Pharmaceuticals, Inc. Common Stock (ARMP)
R&D Expense Growth
24.14%
Quarterly · Period ending:
ARMP R&D Expense Growth
Latest reported24.14%period ending
Latest reported24.14%period ending
ARMP Quarterly R&D Growth (QoQ) (0.00% → 24.14%)
Latest values, visible window
High-resolution chart · PNG
ARMP r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -8.5714% | |
| 12.9032% | |
| -6.0606% | |
| 6.4516% | |
| 0% | |
| -13.8889% | |
| 50% | |
| 0% | |
| 4.3478% | |
| 21.0526% | |
| -5% | |
| 0% | |
| 11.1111% | |
| -5.2632% | |
| 11.7647% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |